A non-hormonal adrenocortical tumor
Deraemaeker, C.; Demey, H.; Das, L.; Mortelmans, L.
Journal Belge de Radiologie 68(5): 363-367
1985
ISSN/ISBN: 0302-7430 PMID: 3912379 Document Number: 264089
Document emailed within 1 workday
Related Documents
Kamiyama, T.; Une, Y.; Satou, Y.; Sano, F.; Uchino, J.; Morita, Y.; Nojima, T. 1990: A case of non-functioning adrenocortical tumor Gan no Rinsho. Japan Journal of Cancer Clinics 36(7): 847-853Taguchi, H.; Ishizuka, E.; Takahashi, T. 1971: Transthoracic extirpation of right giant adrenocortical tumor Shujutsu. Operation 25(7): 813-822
Levy, J.M.; Lutz, P.; Wagner, C.; Sauer, P.; Seiller, F.; Fischbach, M.; Segura, N.; Sauvage, P. 1985: Favorable outcome of a recurring malignant adrenocortical tumor under O,P'-DDD therapy Annales de Pediatrie 32(6): 541-544
Edgren, M.; Eriksson, B.; Wilander, E.; Westlin, J.E.; Nilsson, S.; Oberg, K. 1997: Biological characteristics of adrenocortical carcinoma: a study of p53, IGF, EGF-r, Ki-67 and PCNA in 17 adrenocortical carcinomas Anticancer Research 17(2b): 1303-1309
Sasano, H.; Nakamura, Y. 2011: Differentiation of adrenocortical cells and tumorigenesis of adrenocortical neoplasia Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 2): 463-468
Medina, D.; Faulkin, L.J.; DeOme, K.B. 1970: Combined effects of 3-methylcholanthrene, mammary tumor virus, nodule-inducing virus, and prolonged hormonal stimulation on the tumor-producing capabilities of the nodule outgrowth line D1 Journal of the National Cancer Institute 44(1): 159-165
Moreira, I.F.d.A.; Bianchini, M.P.; Moreira, G.R.C.; Almeida, A.M.; Rezende, B.A. 2020: Sexual function and metabolic/hormonal changes in women using long-term hormonal and non-hormonal contraceptives: a pilot study Bmc Women's Health 20(1): 240
Garcia Giralt, E.; Omodei Zorini, C. 1990: Hormonal treatment of breast tumor La Clinica Terapeutica 132(4): 217-227
López López, C.; Quilez Fenoll, J.M.; Gómez Ruiz, J.J.; López López, A.F.; Romero Maroto, Y.J. 1996: Histologic regression of localized prostatic tumor with neoadjuvant hormonal therapy Archivos Espanoles de Urologia 49(8): 819-823
Krasil'nikov, M.A.; Shatskaia, V.A. 2001: Role of phosphatidylinositol signalling path in developing hormonal resistance in tumor cells Voprosy Onkologii 47(2): 218-223
Jap, T.S.; Kwok, C.F.; Ho, L.T. 1990: Thyrotropin-and prolactin--secreting pituitary tumor dissociated hormonal response to bromocriptine Zhonghua Yi Xue Za Zhi 45(3): 191-195
Rubin, H.; Nomura, T. 1987: Use of lymph in cell culture to model hormonal and nutritional constraints on tumor growth in vivo Cancer Research 47(18): 4924-4931
Yamakami, Y.; Mieno, T.; Tashiro, T.; Moriuchi, A.; Nasu, M. 1994: A case of pulmonary lymphangiomyomatosis diagnosed by biopsy of retroperitoneal tumor and treated with hormonal therapy Nihon Kyobu Shikkan Gakkai Zasshi 32(3): 261-265
Kitamura, K.; Shirato, H.; Shimizu, S.; Miyasaka, K.; Demura, T.; Shinohara, N.; Harabayashi, T. 2000: Real-time tumor-tracking radiotherapy combined with neoadjuvant hormonal therapy for prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 58 Suppl: 326-329
Liu, D.K.; Owens, G.F.; Feil, P.D. 1986: 2',5'-oligoadenylate synthetase activity in human mammary tumors and its potential correlation with tumor growth or hormonal responsiveness Cancer Research 46(12 Part 1): 6207-6210
Vasnetsova, S.S.; Kulik, G.I.; Korol', V.I.; Turkevich, N.M. 1977: Hormonal sensitivity of mammary adenocarcinoma in rats and the capacity of the sulfhydryl groups of this tumor for bindig by various antineoplastic drugs Voprosy Onkologii 23(5): 91-94
Supowit, S.C.; Rosen, J.M. 1982: Hormonal induction of casein gene expression limited to a small subpopulation of 7,12-dimethylbenz(a)anthracene-induced mammary tumor cells Cancer Research 42(4): 1355-1360
Jamin, C. 2003: Traitement hormonal de la ménopause et risque vasculaire : Le traitement hormonal substitutif : WHI un an après - Hormonal treatment of menopause and vascular risk la Lettre du Gynecologue (283): 27-30
Kraljić, I.; Tarle, M. 1987: Evaluation of endocrine therapy of prostate cancer by assessing tumor markers and hormone parameters. Hormonal "cross-over" treatment of false endocrine independent tumors Progress in Clinical and Biological Research 243b: 521-525
McLachlan, R.I.; O'Donnell, L.; Meachem, S.J.; Stanton, P.G.; de, K.; Pratis, K.; Robertson, D.M. 2002: Hormonal regulation of spermatogenesis in primates and man: Insights for development of the male hormonal contraceptive Journal of Andrology 23(2): 149-162